Alphatec Executive Unloads 100,000 Shares for $2 Million on Earnings Beat

Alphatec stock is up 118% year to date on quarterly results that beat expectations. Although currently unprofitable, the company is expecting full-year positive free cash flow in 2025.

The Motley Fool • Dec 9, 2025

ATEC Mourns Passing of Board Member Jeffrey P. Rydin

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologi.

Business Wire • Nov 7, 2025

Top 2 Health Care Stocks That May Fall Off A Cliff This Quarter

As of Oct. 31, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Oct 31, 2025

Alphatec Holdings, Inc. (ATEC) Q3 2025 Earnings Call Transcript

Alphatec Holdings, Inc. ( ATEC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Patrick Miles - Executive Chairman, CEO & President J. Koning - Executive VP & CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Young Li - Jefferies LLC, Research Division Anna Runci - Piper Sandler & Co., Research Division K.

Seeking Alpha • Oct 31, 2025

ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights. Third Quarter 2025 Financial Results   Quarter Ended September 30, 2025 Total revenue $197 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $153 million Non-GAAP operating exp.

Business Wire • Oct 30, 2025

Alphatec (ATEC) Q3 Earnings and Revenues Surpass Estimates

Alphatec (ATEC) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.28 per share a year ago.

Zacks Investment Research • Oct 30, 2025

ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the.

Business Wire • Oct 16, 2025

ATEC to Participate in Upcoming Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025. The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET. The Piper Sandler MedTech and Di.

Business Wire • Aug 8, 2025

These 3 health tech stocks spiked 37% in a day; Time to buy?

While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.

Finbold • Aug 4, 2025

Alphatec (ATEC) Q2 Revenue Jumps 27%

Alphatec (ATEC 30.44%), a medical technology company specializing in spinal surgery solutions, reported earnings on July 31, 2025. The release showed top- and bottom-line figures (GAAP revenue and non-GAAP EPS) that easily topped analyst estimates.

The Motley Fool • Aug 1, 2025